Back

GLP-1 receptor agonists and muscle loss: mechanisms and discussion

29 August 2025 (14:25 - 15:00)
Organised by: Logo
Congress Presentation Part of: Great Debate: do GLP-1 analogues/GLP-1 receptor agonists (GLP-1RAs) worsen muscle loss in cardiometabolic disease? Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

2 More presentations in this session

Presentation thumbnail
GLP-1 receptor agonists therapy induces muscle loss in cardiometabolic disease: pro
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
GLP-1 receptor agonists therapy induces muscle loss in cardiometabolic disease: con
Professor N. Sattar (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Great Debate: do GLP-1 analogues/GLP-1 receptor agonists (GLP-1RAs) worsen muscle loss in cardiometabolic disease?
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 14:25 CET
You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
ESC TV Today
Episode 7: Coronary spasm - Sex differences in heart failure
thumbnail
Congress Session
Challenges in hypertension management

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources